 MIAMI, Nov. 08, 2021 GLOBE NEWSWIRE -- Longeveron Inc. NASDAQ: LGVN Longeveron or Company, a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today announced that the Company will release its third quarter 2021 financial results on Friday, November 12, 2021 before the open of US markets. Management will host a conference call on the same day at 8:30 a.m. ET. 